Evolv Technologies, Inc. Kaplan Fox & Kilsheimer LLP Alerts Investors to a Securities Class Action Against Evolv Technologies Holdings, Inc. (EVLV) – Deadline is December 31, 2024… Read MoreJoin Investigation
Checkpoint Therapeutics, Inc. Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) reminds investors that a complaint has been filed on behalf of purchasers or acquirers of Checkpoint Therapeutics, Inc. (“Checkpoint” or the “Company”) (NASDAQ: CKPT) securities between March 10, 2021 and December 15, 2023 (the “Class Period”). Click Here to Join Investigation. … Read MoreJoin Investigation
The Chemours Company Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of The Chemours Company (“Chemours” or the “Company”)(NYSE: CC). Click Here To Join Investigation…. Read MoreJoin Investigation
Doximity, Inc. Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) reminds investors that a complaint has been filed on behalf of purchasers or acquirers of the common stock of Doximity, Inc. (“Doximity” or the “Company”) (NYSE: DOCS) between February 9, 2022 and April 1, 2024 (the “Class Period”)…. Read MoreJoin Investigation
Vestis Corporation Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Vestis Corporation (“Vestis” or the “Company”) (NYSE: VSTS)…. Read MoreJoin Investigation
Inari Medical, Inc. Kaplan Fox Files Class Action to Recover Losses for Investors Who Purchased Common Stock of Inari Medical, Inc. (NasdaqGS: NARI) for an Expanded Class Period—March 10, 2021 through February 28, 2024… Read More
Barclays iPath Series B S&P 500 VIX Short-Term Futures ETN Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) and Co-Counsel Sperling & Slater LLC has filed a class action suit in the United States District Court for the Southern District of New York against Barclays PLC, Barclays Bank PLC, James E. Staley, Tushar Morzaria and C.S. Venkatakrishnan (“Defendants”). … Read More
Charles River Laboratories International, Inc. A complaint was filed against Charles River Laboratories International, Inc. alleging the company and its executives concealed illegal importation of nonhuman primates used for research. The complaint was filed in Massachusetts federal court against Charles River, James Foster, David Smith and Flavia Pease. This is a class action on behalf of persons and entities that purchased or otherwise acquired Charles River securities between May 5, 2020 and February 21, 2023, inclusive (the Class Period)…. Read More
